IKT Earnings Inhibikase Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.10 | 2026-05-12 | 10-Q |
| FY 2025 | 2025-12-31 | -0.49 | 2026-03-26 | 10-K |
| Q3 2025 | 2025-09-30 | -0.40 | 2025-11-14 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.26 | 2025-08-14 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.15 | 2026-05-12 | 10-Q |
| FY 2025 | 2024-12-31 | -1.16 | 2026-03-26 | 10-K |
| Q3 2025 | 2024-09-30 | -2.03 | 2025-11-14 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.38 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.73 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -3.16 | 2025-03-27 | 10-K |
| Q3 2023 | 2023-09-30 | -2.93 | 2023-11-14 | 10-Q |
| Q2 2023 | 2023-06-30 | -2.09 | 2023-08-14 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.98 | 2024-05-15 | 10-Q |
| FY 2023 | 2022-12-31 | -4.28 | 2024-03-27 | 10-K |
| Q3 2023 | 2022-09-30 | -3.26 | 2023-11-14 | 10-Q |
| Q2 2023 | 2022-06-30 | -2.20 | 2023-08-14 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.18 | 2023-05-15 | 10-Q |
| FY 2022 | 2021-12-31 | -0.81 | 2023-03-31 | 10-K |
| Q3 2022 | 2021-09-30 | -0.61 | 2022-11-14 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.47 | 2022-08-12 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.